Orthofix Medical (OFIX) Net Income towards Common Stockholders (2010 - 2026)

Orthofix Medical (OFIX) has 17 years of Net Income towards Common Stockholders data on file, last reported at -$20.9 million in Q1 2026.

• Quarterly Net Income towards Common Stockholders rose 60.62% year-over-year to -$20.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$41.2 million (up 70.79% YoY) and the FY2025 annual result came in at -$91.1 million, up 26.59% from the prior year.
• Net Income towards Common Stockholders eased to -$20.9 million in Q1 2026, from -$1.1 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $3.6 million in Q2 2025 to a low of -$60.9 million in Q1 2023.
• A 5-year average of -$19.4 million and a median of -$20.9 million in 2026 frame the typical range for Net Income towards Common Stockholders.
• The widest YoY moves for Net Income towards Common Stockholders: up 110.78% in 2025, down 24255.05% in 2025.
• Tracing OFIX's Net Income towards Common Stockholders over 5 years: stood at -$5.8 million in 2022, then tumbled by 279.43% to -$22.2 million in 2023, then slipped by 22.95% to -$27.3 million in 2024, then surged by 95.82% to -$1.1 million in 2025, then sank by 1734.04% to -$20.9 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at -$20.9 million (Q1 2026), -$1.1 million (Q4 2025), and -$22.8 million (Q3 2025), per Business Quant data.